Immunogenicity 11348

summary
Sample ID
3775
Response
Negative
Tumor Type
Cervical Carcinoma(HPV+)
Gene Symbol
OR4K2
Transcript ID
uc001vwh.1
HLA INFO
B*40:01
TCR INFO

No TCR info found!

T cell Tumor cell B*40:01
sequence
Full length protein sequence (314 aa)
MDVGN
1
KSTMS
6
EFVLL
11
GLSNS
16
WELQM
21
FFFMV
26
FSLLY
31
VATMV
36
GNSLI
41
VITVI
46
VDPHL
51
HSPMY
56
FLLTN
61
LSIID
66
MSLAS
71
FATPK
76
MITDY
81
LTGHK
86
TISFD
91
GCLTQ
96
IFFLH
101
LFTGT
106
EIILL
111
MAMSF
116
DRYIA
121
ICKPL
126
HYASV
131
ISPQV
136
CVALV
141
VASWI
146
MGVMH
151
SMSQV
156
IFALT
161
LPFCG
166
PYEVD
171
SFFCD
176
LPVVF
181
QLACV
186
DTYVL
191
GLFMI
196
STSGI
201
IALSC
206
FIVLF
211
NSYVI
216
VLVTV
221
KHHSS
226
RGSSK
231
ALSTC
236
TAHFI
241
VVFLF
246
FGPCI
251
FIYMW
256
PLSSF
261
LTDKI
266
LSVFY
271
TIFTP
276
TLNPI
281
IYTLR
286
NQEVK
291
IAMRK
296
LKNRF
301
LNFNK
306
AMPS
311
Mutation Information
DNA mutation:
None
Peptide Range:
195 ~ 219
Mut AA position:
207 (13 in Wild Type peptide)
Alignment
Wild Type:
"LGLFMISTSGIIALSCFIVLFNSYV
||||||||||||.||||||||||||
Mutant:
LGLFMISTSGIIVLSCFIVLFNSYV"
reference
clinic trial
Checkpoint Blockade

None

ACT

None

Vaccination

None

Curative Effect

None

experiment
minimal_peptide

None

Antigen Type

TMG RNA

T-cell Source

TILs

APC Type

autologous DCs

Assay

IFNg ELISPOT assay